ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 82 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,347,395 | -36.3% | 196,700 | -3.6% | 0.03% | -30.4% |
| Q2 2023 | $2,116,237 | -44.9% | 204,073 | -57.0% | 0.05% | -41.8% |
| Q1 2023 | $3,838,244 | +1038.9% | 474,443 | +2374.4% | 0.08% | +618.2% |
| Q2 2021 | $337,000 | -36.3% | 19,174 | -8.6% | 0.01% | -45.0% |
| Q1 2021 | $529,000 | +58.9% | 20,981 | -59.2% | 0.02% | +66.7% |
| Q4 2020 | $333,000 | +2461.5% | 51,461 | +339.8% | 0.01% | +1100.0% |
| Q3 2019 | $13,000 | -97.6% | 11,700 | -43.5% | 0.00% | -98.9% |
| Q3 2017 | $535,000 | +52.9% | 20,711 | +60.3% | 0.09% | +21.9% |
| Q2 2017 | $350,000 | -62.8% | 12,920 | -59.0% | 0.07% | -58.3% |
| Q1 2017 | $940,000 | +256.1% | 31,545 | +224.8% | 0.18% | +191.7% |
| Q4 2016 | $264,000 | – | 9,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,399,034 | $49,422,000 | 10.17% |
| VR Adviser, LLC | 4,563,962 | $66,360,000 | 9.07% |
| COMMODORE CAPITAL LP | 2,672,346 | $38,856,000 | 9.00% |
| TCG Crossover Management, LLC | 1,082,213 | $15,735,000 | 7.37% |
| Foresite Capital Management V, LLC | 1,258,243 | $18,295,000 | 4.50% |
| Parkman Healthcare Partners LLC | 1,025,522 | $14,911,000 | 3.29% |
| Aisling Capital Management LP | 634,455 | $9,225,000 | 3.25% |
| GREAT POINT PARTNERS LLC | 800,000 | $11,632,000 | 2.58% |
| Samsara BioCapital, LLC | 794,171 | $11,547,000 | 2.24% |
| Affinity Asset Advisors, LLC | 400,000 | $5,816,000 | 2.11% |